# Kay Square Scientific

> Kay Square Scientific is a privately held, remote medical-communications agency founded by Kevin D. Pawley in 2017. It helps global biopharma teams and scientific experts turn preclinical, clinical and health-economics evidence into manuscripts, congress materials, publication plans, patient resources, expert programs and live or virtual events. Its pitch is unusually plain: experienced specialists, doctoral-level scientific writers and careful project management for work where accuracy and compliance matter more than volume.

- **Founded:** 2017
- **Headquarters:** Butler, United States
- **Founders:** Kevin D. Pawley (Founder, President & CEO)
- **Products:** Scientific and medical publications, Live and virtual events, Publication planning and medical affairs support, Expert engagement
- **Notable:** Kay Square staff were credited with writing the first draft of a phase 3 pegcetacoplan manuscript published in the New England Journal of Medicine in December 2025., Kay Square editorial support was acknowledged in another New England Journal of Medicine trial report published in November 2025., Kay Square writers were acknowledged for editorial and medical-writing support in two phase 3 spinal muscular atrophy studies published in Nature Medicine in December 2025.

## Products & services

- **Scientific and medical publications** — Manuscripts, reviews, systematic literature reviews, meta-analyses, white papers, consensus papers, abstracts, posters, slide decks, podcasts, videos, animated infographics, monographs, medication guides, questionnaires, patient resources and lexicons.
- **Live and virtual events** — Planning, materials and execution for advisory boards and roundtable discussions, including slide decks and post-meeting reports.
- **Publication planning and medical affairs support** — Strategic and tactical publication plans and scientific platforms spanning preclinical work through launch and real-world use.
- **Expert engagement** — Peer-to-peer speaker materials and training, medical education materials and programs involving therapeutic-area experts and healthcare professionals.

## Achievements

- Kay Square staff were credited with writing the first draft of a phase 3 pegcetacoplan manuscript published in the New England Journal of Medicine in December 2025.
- Kay Square editorial support was acknowledged in another New England Journal of Medicine trial report published in November 2025.
- Kay Square writers were acknowledged for editorial and medical-writing support in two phase 3 spinal muscular atrophy studies published in Nature Medicine in December 2025.
- The team lists an average of 13 years of medical-communications experience per employee, and all scientific writers are PharmDs or PhDs.
- The agency became an independent corporation in 2020 after beginning as a division of Kay Square Press.

## Latest updates

- **2026-04** — The company highlighted two primary-study manuscripts supported by its team and published in the December 2025 issue of Nature Medicine.
- **2026-02** — The company highlighted two client-supported publications that appeared in the New England Journal of Medicine.
- **2025-12** — Nature Medicine published two phase 3 spinal muscular atrophy papers acknowledging Kay Square staff for editorial and medical-writing support.
- **2025-12** — The New England Journal of Medicine published a phase 3 pegcetacoplan paper crediting three Kay Square writers with the first manuscript draft.

## Links

- Website: https://kaysquare-sci.com/
- LinkedIn: https://www.linkedin.com/company/kaysquarescientific/
- Instagram: https://www.instagram.com/kaysquarescientific/
- Facebook: https://www.facebook.com/profile.php?id=61560416225241

---

Profile page: https://yespress.io/kay-square-scientific
Published by YesPress — https://yespress.io
Last updated: 2026-09-21